Dopamine neuronal tracts in schizophrenia: their pharmacology and in vivo glucose metabolism.
Tamminga
C A
CA
Department of Psychiatry, University of Maryland, Baltimore, Maryland 21228.
Burrows
G H
GH
Chase
T N
TN
Alphs
L D
LD
Thaker
G K
GK
D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001921:Brain / Q000503:physiopathology*; D003952:Diagnostic Imaging; D004298:Dopamine / Q000502:physiology*; D018492:Dopamine Antagonists; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D009474:Neurons / Q000502:physiology*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology*; D012844:Sincalide / Q000502:physiology
D014150:Antipsychotic Agents; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D005947:Glucose; D012844:Sincalide; D004298:Dopamine